Innovation Pharmaceuticals Inc (IPIX)

[F1ash]

" there was no recurrence of psoriasis in animals treated with KM-133, whereas psoriasis recurred after an average of 61 days in animals treated with methotrexate. Immunosuppression in animals treated with KM-133 was less severe than in those treated with efalizumab. "

Sounds like "effectively cured the disease" to me. Much better than treating the symptoms.

Question for the experts, I seem to remember reading in one disclosure that they expected to have to place a boxed warning on "P". I can't refind this statement but wondered if it was related to immunosuppression.